companydata.dkcompanydata.dk

VELOXIS PHARMACEUTICALS A/S: Financial statements 2026

CVR: 26527767

Source: annual report 2026, Danish Business Authority

01/04/2025 – 31/03/2026

VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2026. In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000. The solvency ratio was 99.8%. The company had 1 employee in the financial year.

Profit/Loss
DKK -1,553,000
Equity
DKK 611,587,000
Total Assets
DKK 612,939,000
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026---1.6M611.6M1
2025---88.6M USD1
2024----10.5M USD1
2023---2.8M USD1
20220 USD0 USD2.1M USD2.9M USD-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like VELOXIS PHARMACEUTICALS A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

About VELOXIS PHARMACEUTICALS A/S

VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.

Source: annual report 2026, Danish Business Authority